United Therapeutics (NSDQ:UTHR) has agreed to pay $210 million to squash claims that it used a charity to illegally cover Medicare patients’ out-of-pocket costs in an attempt to boost sales.
Drug companies are not allowed to subsidize co-pays for people enrolled in Medicare, but they can donate to independent non-profits that provide co-pay assistance.
Get the full story at our sister site, Drug Delivery Business News.
The post United Therapeutics dishes out $210m to settle charity-kickback claims appeared first on MassDevice.